Vascular endothelial growth factor assessment in different blood fractions of gastrointestinal cancer patients and healthy controls

Oncology Reports

Volumn 11, Issue 2, 2004, Pages 435-439

  Ranieri, Girolamo ^a   Coviello, Maria ^a   Chiriatti, Annalisa ^a   Stea, Baldassarre ^a   Montemurro, Severino ^a   Quaranta, Michele ^a   Dittadi, Ruggero ^b   Paradiso, Angelo ^a  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^b GENERAL HOSPITAL   (Italy)

Author keywords

Blood fractions; ELISA; Gastrointestinal cancer; Healthy controls; Vascular endothelial growth factor

Indexed keywords

TUMOR MARKER; VASCULOTROPIN A;

AGED; ARTICLE; BLOOD; CANCER STAGING; COLON TUMOR; COMPARATIVE STUDY; GASTROINTESTINAL TUMOR; HUMAN; MIDDLE AGED; PATHOLOGY; RECTUM TUMOR; REFERENCE VALUE; STOMACH TUMOR; VASCULARIZATION;

AGED; COLONIC NEOPLASMS; GASTROINTESTINAL NEOPLASMS; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RECTAL NEOPLASMS; REFERENCE VALUES; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 3242767046     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.11.2.435     Document Type: Article

References (34)

1. Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M, Belien JA, De Waal RM, van Marck E, Magnani E, Weidner N, Harris AL and Dirix LY: Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 38: 1564-1579, 2002. (Pubitemid 34876495)
2. Ranieri G, Labriola A, Achille G, Florio G, Zito AF, Grammatica L and Paradiso A: Microvessel density, mast cell density and thymidine phosphorylase expression in oral squamous carcinoma. Int J Oncol 21: 1317-1323, 2002.
3. Albini A, Morini M, D'agostini F, Ferrari N, Campelli F, Arena G, Noonan DM, Pesce C and De Flora S: Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice by oral N-acetylcysteine. Cancer Res 61: 8171-8178, 2001. (Pubitemid 33091609)
4. Ranieri G and Gasparini G: Surrogate markers of angiogenesis and metastasis. In: Metastasis Research Protocols. Brooks S (ed). Humana Press, Oxford, pp99-114, 2001.
5. Gasparini G, Brooks PC, Biganzoli E, Vermeulen PB, Bonoldi E, Dirix LY, Ranieri G, Miceli R and Cheresh DA: Vascular integrin alpha (v) beta3: a new prognostic indicator in breast cancer. Clin Cancer Res 4: 2625-2634, 1998. (Pubitemid 28523488)
6. Paradiso A, Ranieri G, Silvestris N, Naccarato G, Bevilacqua G, Mangia A, Leone B, Vallejo C, Simone G, Schittulli F and De Lena M: Failure of primary breast cancer neoangiogenesis to predict pattern of distant metastatisation. Clin Exp Med 1: 127-132, 2001. (Pubitemid 34143440)
7. Ranieri G, Passantino L, Patruno R, Passantino G, Jirillo F, Catino A, Mattioli V, Gadaleta C and Ribatti D: The dog mast cell tumour as a model to study the relationship between angiogenesis, mast cell density and tumour malignancy. Oncol Rep 10: 1189-1193, 2003.
8. Ferrara N: The regulation of angiogenesis by vascular endothelial growth factor. Forum 6.4: 393-403, 1996.
9. Ranieri G and Gasparini G: Angiogenesis and angiogenesis inhibitors: a new potential anticancer therapeutic strategy. Curr Drug Targets Immune Endocr Metabol Disord 1: 241-253, 2001.
10. Nicosia RF: What is the role of vascular endothelial growth factor-related molecules in tumor angiogenesis? Am J Pathol 153: 11-16, 1998.
11. Balsari A, Maier IAM, Colnaghi MI and Menard S: Correlation between tumor vascularity, vascular endothelial growth factor production by tumor cells, serum vascular endothelial growth factor levels, and serum antigenic activity in patients with breast carcinoma. Lab Invest 79: 897-902, 1999. (Pubitemid 29344502)
12. Rosfstad EK and Danielsen T: Hypoxia-induced angiogenesis and vascular endothelial growth factor secretion in human melanoma. Br J Cancer 77: 897-902, 1998.
13. Achen MC, Jeltsch M, Kurr E, Makinen T, Vitali A, Wilks AF, Alitalo K and Stacker SA: Vascular endothelial growth factor D (VEGF D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 95: 548-553, 1998. (Pubitemid 28083780)
14. Yamamoto Y, Masakazu T, Kondo S, Matsumoto T, Suzuki H, Masatsugu K, Tsuruta K, Taniguchi T, Okamoto A, Mori T, Yoshida M, Ikeda T and Tominaga T: Concentration of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin Cancer Res 2: 821-826, 1996. (Pubitemid 26168934)
15. Adams J, Carder PI, Downey S, Forbes MA, MacLennan K, Allgar V, Kaufman S, Hallam S, Bicknell R, Walker JJ, Cairnduff F, Selby PI, Perren T J, Lansdown M and Banks RE: Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF microvessel density and effects of tamoxifen. Cancer Res 60: 2898-2905, 2000. (Pubitemid 30395813)
16. Karayannakis AI, Syrigos KN, Polychronidis A, Zbar A, Kouraklis G, Simopoulos C and Karatzas G: Circulating VEGF levels in the serum of gastric cancer patients correlatine with pathological variables, patients survival, and tumour surgery. Ann Surg 236: 37-42, 2002. (Pubitemid 34686448)
17. Wynendaele W, Derua R, Hoylaerts MF, Pawinski A, Waelkens E, De Bruijn EA, Paridaens R, Merlevede W and van Oosterom AT: Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients patients and volunteers: a key to study an angiogenic marker in vivo? Ann Oncol 10: 965-971, 1999. (Pubitemid 29424578)
18. Hyodo I, Doi T, Endo H, Hosokawa Y, Nishikawa Y, Tanimizu M, Jinno K and Kotani Y: Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer. Eur J Cancer 34: 2041-2045, 1998. (Pubitemid 28546939)
19. George ML, Eccles SA, Tutton MG, Abulafi AM and Swift RI: Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin Cancer Res 6: 3147-3152, 2000. (Pubitemid 30637740)
20. Nakayama Y, Sako T, Shibao K, Okazaki k, Rempo N, Onitsuka K, Minagawa N, Akahane K, Nagashima N, Nagata N and Itoh H: Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer. Anticancer Res 22: 2437-2442, 2002. (Pubitemid 34857079)
21. UICC: TNM Classification of Malignant Tumours. 5th edition. Sobin LH Ch Wittekind (ed). Wiley, New York, 1997.
22. American Joint Committee on Cancer: Manual for Staging of Cancer. 3rd edition. Lippincott (ed). Philadelphia, p7, 1988.
23. Dittadi R, Meo S, Fabris F, Gasparini G, Contri D, Medici M and Gion M: Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartments. Int J Biol Markers 16: 87-96, 2001. (Pubitemid 32755125)
24. Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingham E, Walters C and Selby PJ: Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 77: 956-964, 1998. (Pubitemid 28101786)
25. Salven P, Orpana A and Joensuu H: Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Clin Cancer Res 5: 487-491, 1999. (Pubitemid 29131955)
26. Webb NJA, Bottomley MJ, Watson CJ and Brenchley PEC: Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci 94: 395-404, 1998. (Pubitemid 28176624)
27. Gunsilius E, Petzer E, Stockhammer G, Nussbaumer W, Schumacher P, Clausen J and Gastl G: Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood. Oncologist 58: 169-174, 2000. (Pubitemid 30113869)
28. Verheul HMW, Hoekman K, De Bakker SL, Eekman CA, Folman CC, Broxterman HJ and Pinedo HM: Platelet: transporter of vascular endothelial growth factor. Clin Cancer Res 3: 2187-2190, 1997. (Pubitemid 28133134)
29. Jelkmann W: Piftalls in the measurement of circulating vascular endothelial growth factor. Clin Chem 47: 617-623, 2001.
30. Werther K, Bulow S, Hesselfetd P, Jespersen NF, Svendsen MN and Nielsen HJ: VEGF concentrations in tumour arteries and veins from patients with rectal cancer. APMIS 110: 646-650, 2002. (Pubitemid 35335134)
31. Werther K, Christensen IJ and Nielsen HJ: Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leukocytes and platelets. Scand J Clin Lab Invest 62: 343-350, 2002.
32. Davies MM, Jonas SK, Kaur S and Allen-Mersh TG: Plasma vascular endothelial growth factor but not fibroblast growth factor levels correlate with colorectal liver metastasis vascularity and volume. Br J Cancer 82: 1004-1008, 2000. (Pubitemid 30128850)
33. Kim HK, Song KS, Park YS, Kang YH, Lee YJ, Lee KR, Kim HK, Bae JM and Kim S: Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of metastasis predictor. Eur J Cancer 39: 184-189, 2003.
34. Hormbrery E, Gillespie P, Turner K, Han C, Roberts A, McGrouther D and Harris AL: A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: is the current literature meaningful? Clin Exp Metastasis 19: 651-663, 2002. (Pubitemid 36092260)